A wearable ultrasound scanner could detect breast cancer earlier
Tiny surgical robots could transform detection and treatment of cancers. A tiny robot which can travel deep into the lungs to detect and treat the first signs of cancer has…
Research team develops new system for imaging and treating tumors
UC San Diego First to Test Cancer Drugs in Space Using Private Astronaut Mission
New Blood-Vessel-on-a-Chip Can Help Researchers Further Understand Vascular Malformations. A research team led by William Polacheck, Ph.D., at the UNC School of Medicine, has engineered a microfluidic model that mimics…
Lumitron Technologies FLASH radiotherapy set to transform Cancer Treatment and Clinical Radiography
Scientists develop powerful AI algorithm SPHINKS to gain new insights into deadly glioblastoma
“Best Use of Artificial Intelligence in BioTech 2022” awarded to Known Medicine
Experimental cancer therapy shows success in more than 70% of patients in global clinical trials.
Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm.
BEES-HAUS autologous buccal mucosal cell therapy to manage male urethral stricture, has been confirmed for cell engraftment, holding potentials to prevent stricture recurrence. Steps underway for a larger study in…
The MEVION S250-FIT would be the first and only proton therapy system that can be installed in an existing LINAC vault.
Researchers from NYU Langone Health aim to improve breast cancer diagnostics with a new AI model.
Exact Sciences data from a multi-cancer early detection (MCED) biomarker validation study was presented at the European Society for Medical Oncology (ESMO) Congress
Data will Inform the Largest Registrational Multi-Cancer Early Detection Study Ever Conducted in the United States to Support Another Leading Test in Exact Sciences' Screening Portfolio.
Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients
Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients. Presentations will include evidence on how genomic signatures and next-generation sequencing can improve the…
Latest version of Galen™ transforms diagnosis of prostate, breast and gastric cancer and includes expanded detection, user-interface, and workflow integration capabilities.